EBM — Eastwood Bio-Medical Canada Cashflow Statement
0.000.00%
Last trade - 00:00- CA$66.82m
- CA$66.87m
- CA$0.70m
Annual cashflow statement for Eastwood Bio-Medical Canada, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.852 | -0.604 | -0.15 | -0.547 | -0.456 |
| Depreciation | |||||
| Non-Cash Items | 0.02 | -0.012 | 0.005 | 0.004 | 0.021 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.184 | 0.394 | 0.034 | 0.418 | 0.312 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.543 | -0.116 | -0.004 | -0.017 | -0.015 |
| Capital Expenditures | 0 | -0.006 | -0.003 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.006 | -0.003 | — | — |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.04 | 0.02 | 0.026 | -0.004 | -0.005 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.503 | -0.102 | 0.019 | -0.021 | -0.02 |